MyOPE: Malicious securitY for Oblivious Polynomial Evaluation In this work, we introduce MyOPE, a \short-sighted" non-interactive polynomial evaluation scheme with a poly-logarithmic communication complexity in the presence of malicious senders
MyOPE for LIP6 We will need to prove the computation of scalar products with respect to commited vectors is correct Some of these vectors could be private The N-degree coefficient of the product of these polynomials is c The polynomial: The prover commits a, b, and d into the appropriate subspaces of the space of polynomials with coefficients mod q
MyOPE: Malicious SecuritY for Oblivious Polynomial Evaluation In this work, we introduce MyOPE, a “short-sighted” non-interactive polynomial evaluation scheme with a poly-logarithmic communication complexity in the presence of malicious senders
MyOPE: Malicious securitY for Oblivious Polynomial Evaluation MyOPE builds on generic secure encodings techniques that allow composite integers and enable real-world FHE parameters and even RNS-based optimizations It is best adapted for the unbalanced setting where the degree of the polynomial and the computing power of the sender are large
IMI – Clinical Management Guidelines Report This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management
OPX50727 463. . 465 Myopic maculopathy is characterized by stretched blood ves-sels, peripapillary atrophy, posterior staphyloma, lacquer cracks in the Bruch membrane, geographic atrophy of the retinal pigment epithelium and choroid, subretinal hemorrhages, and choroidal neovascularization
The Risks and Benefits of Myopia Control - Ophthalmology Purpose: The prevalence of myopia is increasing around the world, stimulating interest in methods to slow its progression The primary justification for slowing myopia progression is to reduce the risk of vision loss through sight-threatening ocular pathologic features in later life